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Muscle development: Electrical control of gene expression
Simon M. Hughes
The electrical activity resulting from stimulation by
motor neurons regulates gene expression in skeletal
muscle fibres. A recent study has suggested a
mechanism by which distinct patterns of electrical
stimulus might be integrated to control the contractile
properties of these fibres.
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What happens when one decides, as people of a certain
age do, that it is time to run a marathon? The masochism
of a training regime is designed to tune that flabby muscle
into the ultimate racing machine. The result? We don’t
reach the Olympics, but we do make it to the finishing
line, even though the first 5 kilometre practice run nearly
brought us to our last gasping breath. The reason why we
succeed is, in part, the training effect of increased neural
stimulation on skeletal muscle fibres, through changing
gene expression in the fibres. But how do muscle fibres
use this increased neural activity, experienced a few times
a week, to change their properties sufficiently to permit a
successful marathon attempt? Recent work from Chin et
al. [1] has taken us another step, but by no means the final
one, towards unravelling this mystery.
Muscle fibres are specialised for particular tasks. Our
fastest fibres express a fast isoform of the muscle 
motor protein myosin which hydrolyses ATP rapidly and
generates high levels of force. Such fibres fatigue rapidly
because they use inefficient glycolytic metabolism to 
generate ATP quickly. In contrast, slow fibres express the
slow isoform of myosin, which hydrolyses ATP more
slowly. Efficient oxidative metabolism can generate ATP
rapidly enough to fuel these fibres. The trick in marathon
running is to maximise the oxidative generation of ATP
and use that energy to keep up a steady pace. Conse-
quently, slow oxidative fibres are abundant in Olympic
marathon runners [2]. Conversely, fast fibres are more
common in athletes excelling at short-term strength
events like the high jump or javelin, for which efficiency
is less important and acceleration is everything.
In adult animals, the gene expression in muscle fibres is
regulated, at least in part, by the electrical activity that the
fibres receive from their motor neurons. Slow fibres are
stimulated at a continuous low frequency, whereas fast
fibres experience bursts of high-frequency firing inter-
spersed with periods of rest. Applying these firing patterns
to fibres of either type can induce the expression of the
appropriate genes — if given a continuous, low-frequency
stimulus, fast fibres can be induced to express genes that
are usually expressed in slow fibres, and vice versa.
Understanding how these types of electrical stimulus are
integrated over time and translated into a command to
activate the expression of specific genes forms the subject
of discussion.
In the study by Chin et al. [1], the investigation began
with studies of two mouse genes that are regulated by
electrical activity. Myoglobin is highly expressed in oxida-
tive fibres to facilitate diffusion of oxygen from the blood
to the mitochondria. Troponin-Islow is a specialized
subunit of the trimeric troponin complex which mediates
the calcium-sensitive activation of muscle contraction by
exposing the actin filament in muscle fibres to myosin.
The regulatory regions that control the expression of the
myoglobin and troponin-Islow genes have binding sites for
transcription factors of the nuclear factor of activated 
T cells (NFAT) family, originally found to be involved in
T-cell signalling but now known to be expressed in a
number of other cell types. Chin et al. [1] introduced
reporter gene constructs driven by these regulatory
regions into a mouse muscle cell line and demonstrated
that NFAT is capable of activating the expression of the
reporter gene. NFAT had no effect on the expression of a
reporter gene driven by a variety of control promoter or
enhancer elements, however. 
Why is it interesting for muscle gene expression that
activation of a known transcription factor leads to
increased expression of reporter genes driven by its
cognate DNA-binding site? The answer lies in the
known pathway of activation of NFAT. Nuclear entry by
NFAT, and hence NFAT-mediated transcriptional acti-
vation, is regulated by NFAT phosphorylation
(Figure 1). NFAT proteins are retained in the cytoplasm
when phosphorylated, but rapidly enter the nucleus
when the phosphate group is removed. Dephosphoryla-
tion can be effected by calcineurin, a calcium-sensitive
serine/threonine phosphatase that is activated transiently
in the presence of calcium–calmodulin. The calcineurin
pathway is more sensitive than some other calcium-
dependent pathways to small rises in calcium levels, yet
calcineurin inactivates rapidly after a transient peak of
calcium [3,4]. These properties suggest that calcineurin
would be sensitive to the higher average calcium signal
thought to prevail in chronically active slow fibres, yet
unresponsive to the calcium transients in response to
electrical activity in fast muscle fibres. 
Chin et al. [1] used the drug cyclosporin A (CsA) to test
this idea. CsA inhibits calcineurin and therefore is pre-
dicted to prevent slow-fibre-specific gene expression by
blocking the effects of increased intracellular calcium.
Around 20% of the slow fibres in the soleus muscle of rats
treated with CsA were converted to fast fibres, as revealed
by the induction of expression of a myosin isoform that
had the enzymatic and immunological properties of fast
myosin. But the analysis of the expression of the endo-
genous slow-fibre-specific genes that contain NFAT sites
in their regulatory regions was not reported in the study.
CsA has been shown previously to induce loss of oxidative
capacity in muscle cells, however, suggesting that it can
inhibit the function of slow muscle fibres and possibly
change muscle fibre type [5]. Thus, the work raises the
possibility that NFAT proteins may be important regula-
tors of muscle-specific gene expression and is consistent
with the expression of a variety of NFAT transcription
factors in human muscle cells [6,7].
As the authors themselves point out, the work leaves a
number of issues still to be resolved. Chief among them is
whether a calcineurin-dependent pathway mediates the
effect of electrical activity patterns on fibre-type-specific
gene expression, and, if so, whether calcineurin regulates
most of the genes that are specifically expressed in slow
muscle fibres or only a limited subset. The answer will
come from a more detailed analysis of the CsA-treated
animals than has so far been reported. CsA is a potent
immunosuppressant and, given that CsA has a dramatic
effect on animal behaviour and muscle regeneration [5,7],
it is far from clear that CsA acts directly within muscle
fibres. Even minor changes in neural activity have been
previously reported to alter muscle fibre types, so effects of
CsA on the nervous system should not be discounted.
From another angle, the apparent lack of effect of CsA on
80% of the slow fibres in the soleus muscle is particularly
intriguing. Are these fibres receiving a pattern of electrical
activity that the administered doses of CsA are unable to
block? Or are the affected fibres fundamentally different
from the majority? In either case, the small change
observed is reminiscent of the small increases in soleus fast
fibres seen in mice deficient in another transcription factor,
MyoD [8]. Perhaps calcineurin has a sufficiently broad sub-
strate specificity to affect several transcription factors,
thereby co-ordinating expression of a variety of genes.
Another issue that must be addressed is whether the
NFAT sites in the regulatory regions of slow-muscle-
specific genes are actually required for fibre-type-specific
expression of the exogenous reporter genes or of the 
corresponding endogenous genes. A recent examination of
the troponin-Islow gene has revealed that the NFAT site
can be removed without preventing slow-fibre-specific
expression in transgenic mice [9]. For other genes, it may
also be necessary to address this issue in the intact animal,
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Figure 1
The NFAT pathway and the suggested role of
electrical activity. (a,b) Diagrammatic view of
the effects of distinct firing patterns on the
activity of various components of the pathway.
(a) Bursts of firing in fast muscle fibres cause
transient elevation of intracellular free calcium,
which may be unable to induce sufficient
calcineurin activity to dephosphorylate NFAT.
(b) Steady firing in slow fibres may prevent
calcium falling to basal levels for long periods,
so calcineurin remains active and
dephosphorylates NFAT, allowing NFAT to
enter the nucleus and activate the
transcription of slow-fibre-specific genes.
(c) The proposed calcineurin signal
transduction pathway in slow fibres (see text
for details). Abbreviations: CaM, calmodulin;
TnI, troponin-I.
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because cultured muscle cells are similar to nascent
embryonic fibres in that they differentially express fibre-
type-specific genes in the absence of imposed electrical
activity (see [10] for an example). Electrical stimulation of
cultured cells has been shown to alter myotube gene
expression [11], however, so analysis of at least some
genes may be possible in culture. 
The big question athletes should be asking is: how much
voluntary training does it take to alter muscle fibre type?
Sadly, it seems humans can do little about their expression
of the different myosin isoforms, as we simply don’t have
that much control over our motor neurons. But the good
news is that running a marathon is achievable because,
with training, we can induce a greater oxidative power in
our fast fibres. Could drugs help? Despite the enthusiasm
of certain athletes and body builders for a drug that could
enhance fast muscle, it is unlikely that anyone will win 
an Olympic strength event by taking potent immuno-
suppressants like CsA.
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